Metastatic bladder cancer is a disease that has had no major treatment advances in nearly 30 years.1
Bladder cancer is one of the top ten most common cancers in the world.2
430,000 new cases diagnosed globally in 2012.
165,000 deaths globally each year.
About 1 in 10 bladder cancers have already spread by the time they are diagnosed.4
Advanced bladder cancer is associated with a poor prognosis.
These statistics demonstrate the need for new treatment options.
- 1. Kim, J. Immune checkpoint blockade therapy for bladder cancer treatment. Investig Clin Urol. 2016; 57(Suppl 1): S98–S105
- 2. Ferlay J et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr. Accessed May 2016
- 3. National Cancer Institute: PDQ® Bladder Cancer Treatment. Bethesda, MD: National Cancer Institute. Date last modified July 2015. Available at: http://www.cancer.gov/types/bladder/patient/bladder-treatment-pdq. Accessed May 2016
- 4. National Cancer Institute: SEER Stat Fact Sheets: Bladder Cancer. Available at: http://seer.cancer.gov/statfacts/html/urinb.html. Accessed May 2016